PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

Chart, page-3958

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    I'm hoping PAR do not enter into a trading halt just to release the results of a couple of secondary endpoints, it just seems overkill IMO. I've never seen a biopharma company place such a great deal of emphasis into their lower level secondary endpoints than PAR has. Other companies normally just released them to no fanfare at all, but i'm half expecting PAR to go into trading halt over the long weekend in typical PAR style. Anyway I'm hoping to still see some separation between the treatment and placebo groups as this will indicate not only possible durability but also disease-modifying properties.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.